Since its establishment in 2009, CanSino Biologics Inc. has been dedicated to exploring the best solutions to the prevention of infectious and contagious diseases through cutting-edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. CanSinoBIO is not only a practitioner of the pharmaceutical industry, a driver of R&D innovation, and an enabler in international cooperation, but also a bearer of social responsibility.

In recent years, CanSinoBIO has earned valuable trust from clients, business partners and the public all over the world with excellent products, high sense of social responsibility and good business reputation, which stems from our integrity, trustworthiness and compliance in the research and development, production and business events. In the process of establishing excellent goodwill, CanSinoBIO always abides by the belief of complying with the rules and laws.

It is integrity, ethics and compliance that are important for CanSinoBIO to keep the public's trust, respect and recognition, and achieve sustainable business development and success, both now and in the future. Therefore, it is very important for CanSinoBIO to hold fast to integrity, ethics and compliance, which requires every employee of CanSinoBIO to abide by the highest standards of ethics, fulfill the promise of compliance and ethics together, act and behave in good faith, strictly follow the industry norms, respect contracts, keep credit, refuse to bribe, compete fairly, and comprehensively improve the ability to manage enterprises according to law.